Best Practice & Research Clinical Rheumatology
Volume 22, Issue 1 , Pages 129-148 , March 2008

Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations

  • Ogo I. Egbuna, MD (Instructor in Medicine)

      Affiliations

    • Corresponding Author InformationCorresponding author. Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, EBRC, Room 209, 221 Longwood Avenue, Boston, MA 02115, USA. Tel.: +1 617 732 6353; Fax: +1 617 582 6193.

References 

  1. Tfelt-Hansen J, Brown EM. The calcium-sensing receptor in normal physiology and pathophysiology: a review. Critical Reviews in Clinical Laboratory Sciences. 2005;42:35–70
  2. Brown EM, Gamba G, Riccardi D, et al. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993;366:575–580
  3. Wellendorph P, Hansen KB, Balsgaard A, et al. Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids. Molecular Pharmacology. 2005;67:589–597
  4. Wellendorph P, Brauner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor. Gene. 2004;335:37–46
  5. Pi M, Faber P, Ekema G, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. The Journal of Biological Chemistry. 2005;280:40201–40209
  6. Hendy GN, D'Souza-Li L, Yang B, et al. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Human Mutation. 2000;16:281–296
  7. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:6062–6067
  8. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiological Reviews. 2001;81:239–297
  9. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism. In:  Wilson JD,  Foster DW,  Kronenberg HM,  Larsen PR editor. Williams textbook of endocrinology. 9th edn.. Philadelphia: W.B. Saunders; 1998;p. 1155–1209
  10. Fudge NJ, Kovacs CS. Physiological studies in heterozygous calcium sensing receptor (CaSR) gene-ablated mice confirm that the CaSR regulates calcitonin release in vivo. BMC Physiology. 2004;4:5
  11. Hebert SC, Cheng S, Geibel J. Functions and roles of the extracellular Ca2+-sensing receptor in the gastrointestinal tract. Cell Calcium. 2004;35:239–247
  12. Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. The Journal of Clinical Endocrinology and Metabolism. 1983;56:572–581
  13. Brown AJ, Zhong M, Finch J, et al. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. American Journal of Physiology. 1996;270:F454–F460
  14. Yarden N, Lavelin I, Genina O, et al. Expression of calcium-sensing receptor gene by avian parathyroid gland in vivo: relationship to plasma calcium. General and Comparative Endocrinology. 2000;117:173–181
  15. Mizobuchi M, Hatamura I, Ogata H, et al. Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency. Journal of the American Society of Nephrology. 2004;15:2579–2587
  16. Bajwa A, Horst RL, Beckman MJ. Gene profiling the effects of calcium deficiency versus 1,25-dihydroxyvitamin D induced hypercalcemia in rat kidney cortex. Archives of Biochemistry and Biophysics. 2005;438:182–194
  17. Ward DT, Riccardi D. Renal physiology of the extracellular calcium-sensing receptor. Pflügers Archiv. 2002;445:169–176
  18. Riccardi D, Lee WS, Lee K, et al. Localization of the extracellular Ca(2+)-sensing receptor and PTH/PTHrP receptor in rat kidney. American Journal of Physiology. 1996;271:F951–F956
  19. Riccardi D, Hall AE, Chattopadhyay N, et al. Localization of the extracellular Ca2+/polyvalent cation-sensing protein in rat kidney. American Journal of Physiology. 1998;274:F611–F622
  20. Ba J, Brown D, Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. American Journal of Physiology. Renal Physiology. 2003;285:F1233–F1243
  21. Motoyama HI, Friedman PA. Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. American Journal of Physiology. Renal Physiology. 2002;283:F399–F406
  22. Sands JM, Naruse M, Baum M, et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. The Journal of Clinical Investigation. 1997;99:1399–1405
  23. Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. The Journal of Biological Chemistry. 2002;277:30337–30350
  24. Riccardi D, Traebert M, Ward DT, et al. Dietary phosphate and parathyroid hormone alter the expression of the calcium-sensing receptor (CaR) and the Na+-dependent Pi transporter (NaPi-2) in the rat proximal tubule. Pflugers Archiv. 2000;441:379–387
  25. Quarles LD, Hartle JE, Middleton JP, et al. Aluminum-induced DNA synthesis in osteoblasts: mediation by a G-protein coupled cation sensing mechanism. Journal of Cellular Biochemistry. 1994;56:106–117
  26. Chang W, Tu C, Chen T-H, et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology. 1999;140:5883–5893
  27. Chattopadhyay N, Yano S, Tfelt-Hansen J, et al. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology. 2004;145:3451–3462
  28. Wu S, Palese T, Mishra OP, et al. Effects of Ca2+ sensing receptor activation in the growth plate. FASEB Journal. 2004;18:143–145
  29. Kanatani M, Sugimoto T, Kanzawa M, et al. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. Biochemical and Biophysical Research. 1999;261:144–148
  30. Yamaguchi T, Ye C, Chattopadhyay N, et al. Enhanced expression of extracellular calcium sensing receptor in monocyte-differentiated versus undifferentiated HL-60 cells: potential role in regulation of a nonselective cation channel. Calcified Tissue International. 2000;66:375–382
  31. Lorget F, Kamel S, Mentaverri R, et al. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochemical and Biophysical Research. 2000;268:899–903
  32. Shalhoub V, Grisanti M, Padagas J, et al. In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells. Critical Reviews in Eukaryotic Gene Expression. 2003;13:89–106
  33. Zaidi M, Adebanjo OA, Moonga BS, et al. Emerging insights into the role of calcium ions in osteoclast regulation. Journal of Bone and Mineral Research. 1999;14:669–674
  34. Garrett JE, Capuano IV, Hammerland LG, et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. The Journal of Biological Chemistry. 1995;270:12919–12925
  35. Ray K, Clapp P, Goldsmith PK, Spiegel AM. Identification of the sites of N-linked glycosylation on the human calcium receptor and assessment of their role in cell surface expression and signal transduction. The Journal of Biological Chemistry. 1998;273:34558–34567
  36. Bai M, Trivedi S, Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. The Journal of Biological Chemistry. 1998;273:23605–23610
  37. Bai M, Quinn S, Trivedi S, et al. Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor. The Journal of Biological Chemistry. 1996;271:19537–19545
  38. Sanders JL, Chattopadhyay N, Kifor O, et al. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy. Biochemical and Biophysical Research. 2000;269:427–432
  39. Hu J, McLarnon SJ, Mora S, et al. A region in the seven-transmembrane domain of the human Ca2+ receptor critical for response to Ca2+. The Journal of Biological Chemistry. 2005;280:5113–5120
  40. Brown EM. Calcium sensing by endocrine cells. Endocrine Pathology. 2004;15:187–220
  41. Nemeth EF, Steffey ME, Hammerland LG, et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proceedings of the National Academy of Sciences of the United States of America. 1998;95:4040–4045
  42. Brown EM, Fuleihan Ge-H, Chen CJ, Kifor O. A comparison of the effects of divalent and trivalent cations on parathyroid hormone release, 3′,5′-cyclic-adenosine monophosphate accumulation, and the levels of inositol phosphates in bovine parathyroid cells. Endocrinology. 1990;127:1064–1071
  43. Ye C, Ho-Pao CL, Kanazirska M, et al. Amyloid-beta proteins activate Ca(2+)-permeable channels through calcium-sensing receptors. Journal of Neuroscience Research. 1997;47:547–554
  44. Conigrave AD, Quinn SJ, Brown EM. L-amino acid sensing by the extracellular Ca2+-sensing receptor. Proceedings of the National Academy of Sciences of the United States of America. 2000;97:4814–4819
  45. Gowen M, Stroup GB, Dodds RA, et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. The Journal of Clinical Investigation. 2000;105:1595–1604
  46. Heath D. Familial benign hypercalcemia. Trends in Endocrinology and Metabolism. 1989;1:6–9
  47. Auwerx J, Demedts M, Bouillon R. Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia. Acta Endocrinologica (Copenh). 1984;106:215–218
  48. Marx SJ, Attie MF, Levine MA, et al. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine (Baltimore). 1981;60:397–412
  49. Attie MF, Gill J, Stock JL, et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. The Journal of Clinical Investigation. 1983;72:667–676
  50. Fuleihan Gel H. Familial benign hypocalciuric hypercalcemia. Journal of Bone and Mineral Research. 2002;17(Suppl 2):N51–N56
  51. Marx SJ, Attie MF, Stock JL, et al. Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 1981;52:736–740
  52. Warner J, Epstein M, Sweet A, et al. Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. Journal of Medical Genetics. 2004;41:155–160
  53. Simonds WF, James-Newton LA, Agarwal SK, et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore). 2002;81:1–26
  54. Carling T, Szabo E, Bai M, et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. The Journal of Clinical Endocrinology and Metabolism. 2000;85:2042–2047
  55. Burski K, Torjussen B, Paulsen AQ, et al. Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: coincidence or causality?. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1015–1016
  56. Janicic N, Pausova Z, Cole DE, Hendy GN. Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. American Journal of Human Genetics. 1995;56:880–886
  57. D'Souza-Li L, Canaff L, Janicic N, et al. An acceptor splice site mutation in the calcium-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Human Mutation. 2001;18:411–421
  58. Hauache OM. Extracellular calcium-sensing receptor: structural and functional features and association with diseases. Brazilian Journal of Medical and Biological Research. 2001;34:577–584
  59. Lloyd SE, Pannett AA, Dixon PH, et al. Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. American Journal of Human Genetics. 1999;64:189–195
  60. Bai M, Pearce SH, Kifor O, et al. In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. The Journal of Clinical Investigation. 1997;99:88–96
  61. Pearce SH, Trump D, Wooding C, et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. The Journal of Clinical Investigation. 1995;96:2683–2692
  62. Marx SJ, Fraser D, Rapoport A. Familial hypocalciuric hypercalcemia. Mild expression of the gene in heterozygotes and severe expression in homozygotes. American Journal of Medicine. 1985;78:15–22
  63. Brown EM, Bai M, Pollak MR. Familial benign hypocalciuric hypercalcemia and other syndromes of altered responsiveness to extracellular calcium. In:  Krane S,  Avioli LV editor. Metabolic bone diseases and clinically related disorders. 3rd edn.. San Diego: Academic Press; 1997;p. 479–499
  64. Grantmyre E. Roentgenographic features of ‘primary’ hyperparathyroidism in infancy. Journal of the Canadian Association of Radiologists. 1973;24:257–260
  65. Cole DE, Janicic N, Salisbury SR, Hendy GN. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. [published erratum appears in Am J Med Genet 1997; 72: 251–252] American Journal of Medical Genetics. 1997;71:202–210
  66. Brown EM. Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. Endocrinology and Metabolism Clinics of North America. 2000;29:503–522
  67. Eftekhari F, Yousefzadeh D. Primary infantile hyperparathyroidism: clinical, laboratory, and radiographic features in 21 cases. Skeletal Radiology. 1982;8:201–208
  68. Aida K, Koishi S, Inoue M, et al. Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene. The Journal of Clinical Endocrinology and Metabolism. 1995;80:2594–2598
  69. Fukumoto S, Chikatsu N, Okazaki R, et al. Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia. Diagnostic Molecular Pathology. 2001;10:242–247
  70. Pollak MR, Chou YH, Marx SJ, et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. The Journal of Clinical Investigation. 1994;93:1108–1112
  71. Kobayashi M, Tanaka H, Tsuzuki K, et al. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 1997;82:2716–2719
  72. Schwarz P, Larsen NE, Lonborg Friis IM, et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism associated with mutations in the human Ca2+-sensing receptor gene in three Danish families. Scandinavian Journal of Clinical and Laboratory Investigation. 2000;60:221–227
  73. Pollak MR, Brown EM, Estep HL, et al. Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nature Genetics. 1994;8:303–307
  74. Winer KK, Yanovski JA, Sarani B, Cutler GB. A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3480–3486
  75. Lienhardt A, Bai M, Lagarde JP, et al. Activating mutations of the calcium-sensing receptor: management of hypocalcemia. The Journal of Clinical Endocrinology and Metabolism. 2001;86:5313–5323
  76. Finegold DN, Armitage MM, Galiani M, et al. Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3q13. Pediatric Research. 1994;36:414–417
  77. Lienhardt A, Garabedian M, Bai M, et al. A large homozygous or heterozygous in-frame deletion within the calcium-sensing receptor's carboxylterminal cytoplasmic tail that causes autosomal dominant hypocalcemia. The Journal of Clinical Endocrinology and Metabolism. 2000;85:1695–1702
  78. Pearce SH, Williamson C, Kifor O, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. The New England Journal of Medicine. 1996;335:1115–1122
  79. Baron J, Winer KK, Yanovski JA, et al. Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Human Molecular Genetics. 1996;5:601–606
  80. D'Souza-Li L, Yang B, Canaff L, et al. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. The Journal of Clinical Endocrinology and Metabolism. 2002;87:1309–1318
  81. Hirai H, Nakajima S, Miyauchi A, et al. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia. Journal of Human Genetics. 2001;46:41–44
  82. Valenti G, Procino G, Tamma G, et al. Minireview: aquaporin 2 trafficking. Endocrinology. 2005;146:5063–5070
  83. Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet. 2002;360:692–694
  84. Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. Journal of the American Society of Nephrology. 2002;13:2259–2266
  85. Vezzoli G, Arcidiacono T, Paloschi V, et al. Autosomal dominant hypocalcemia with mild type 5 Bartter syndrome. Journal of Nephrology. 2006;19:525–528
  86. Hu J, Mora S, Weber G, et al. Autosomal dominant hypocalcemia in monozygotic twins caused by a de novo germline mutation near the amino-terminus of the human calcium receptor. Journal of Bone and Mineral Research. 2004;19:578–586
  87. Bettinelli A, Vezzoli G, Colussi G, et al. Genotype-phenotype correlations in normotensive patients with primary renal tubular hypokalemic metabolic alkalosis. Journal of Nephrology. 1998;11:61–69
  88. Lovlie R, Eiken HG, Sorheim JI, Boman H. The Ca(2+)-sensing receptor gene (PCAR1) mutation T151M in isolated autosomal dominant hypoparathyroidism. Human Genetics. 1996;98:129–133
  89. Koishi S, Aida K, Tawata M, Onaya T. Polymorphism of the human Ca(2+)-sensing receptor gene in Japanese individuals: no relation to non-insulin dependent diabetes mellitus. Hormone and Metabolic Research. 1996;28:541–544
  90. Cetani F, Pinchera A, Pardi E, et al. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenomas. Journal of Bone and Mineral Research. 1999;14:878–882
  91. Scillitani A, Guarnieri V, De Geronimo S, et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. The Journal of Clinical Endocrinology and Metabolism. 2004;89:5634–5638
  92. Cole DE, Peltekova VD, Rubin LA, et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet. 1999;353:112–115
  93. Vezzoli G, Tanini A, Ferrucci L, et al. Influence of the calcium-sensing receptor gene on urinary calium excretion in stone forming patients. Journal of the American Society of Nephrology. 2002;13:2517–2523
  94. Block GA, Martin KJ, de Francisco AL, et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. The New England Journal of Medicine. 2004;350:1516–1525
  95. Nemeth EF, Fox J, Delmar EG, et al. Stimulation of parathyroid hormone secretion by a small molecule antagonist of the calcium receptor. Journal of Bone and Mineral Research. 1998;23:S156;[abstract 1030]

PII: S1521-6942(07)00130-1

doi: 10.1016/j.berh.2007.11.006

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 1 , Pages 129-148 , March 2008

Article Tools

* Image Usage & Resolution